GRANT H. LOUIE M.D. NPI 1306013214

NPI Details

Grant H. Louie, M.D. is a rheumatology internal medicine in Wheaton, MD with 25 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Grant H. Louie, M.D. NPI is 1306013214. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2001

The provider's business location address is:

2730 UNIVERSITY BLVD W STE 310
WHEATON, MD
ZIP 20902-990
Phone: (301) 942-7600
Fax: (301) 942-3132

The NPI 1306013214 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Vitamin d-3 level (HCPCS:82306)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Screening test for antibody to noninfectious agent (HCPCS:86255)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Screening test for autoimmune disorder (HCPCS:86038)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Rheumatoid factor level (HCPCS:86431)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Uric acid level, blood (HCPCS:84550)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Total protein level, urine (HCPCS:84156)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Calcium level, total (HCPCS:82310)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Protein measurement, serum (HCPCS:84165)

The enumeration date for this NPI number is 5/9/2008 and was last updated on 9/27/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.